Clinical Trials Directory

Trials / Completed

CompletedNCT03885414

Virtual Reality Exposure Therapy for Public Speaking Anxiety

Virtual Reality Exposure Therapy for Public Speaking Anxiety: A Multiple-baseline Effectiveness Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Stockholm University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Virtual Reality exposure therapy (VRET) is an efficacious treatment for anxiety disorders but has yet to be implemented in regular care settings. This is arguably due to the limitations of the past generation of VR technology, which was expensive, inaccessible, cumbersome and hard to use. With the advent of consumer VR technology, VRET is now ready for implementation in regular care. This multiple-baseline trial will examine the effectiveness of VRET for public speaking anxiety (PSA) when delivered under real-world conditions at an ordinary, non-specialized mental health clinic, by clinical psychologist with only brief VRET training. Participants will either be self-referred specifically for this treatment, or come through ordinary clinical channels. Self-rated PSA will serve as primary outcome measure and will be measured three times prior to treatment (at screening and twice after a diagnostic screening telephone interview) , four times after onset, at the end of the treatment period, and three months after treatment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALIn-session Virtual Reality exposure therapyA series of exposure exercises (speech exercises) in front of a virtual audience, focusing on promoting inhibitory learning, with audio-feedback.
BEHAVIORALInternet-administered transition programFour-module internet program with weekly therapist guidance, focusing on transitioning to in-vivo exposure in everyday settings.

Timeline

Start date
2019-01-14
Primary completion
2019-09-30
Completion
2019-09-30
First posted
2019-03-21
Last updated
2020-01-23

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT03885414. Inclusion in this directory is not an endorsement.